Natco Pharma gains on the bourses

31 Jan 2019 Evaluate

Natco Pharma is currently trading at Rs. 683.70, up by 6.40 points or 0.94% from its previous closing of Rs. 677.30 on the BSE.

The scrip opened at Rs. 698.00 and has touched a high and low of Rs. 700.00 and Rs. 676.00 respectively. So far 19013 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 973.00 on 01-Feb-2018 and a 52 week low of Rs. 637.40 on 09-Oct-2018.

Last one week high and low of the scrip stood at Rs. 700.00 and Rs. 660.00 respectively. The current market cap of the company is Rs. 12506.56 crore.

The promoters holding in the company stood at 48.42%, while Institutions and Non-Institutions held 29.91% and 21.67% respectively.

Natco Pharma and Alvogen Pine Brook LLC, USA, have submitted Abbreviated New Drug Application (ANDA) containing a paragraph IV certification with the US Food and Drug Administration (USFDA) for generic version of Ibrutinib Tablets of 140mg, 280mg, 420mg and 560mg strength (proposed generic equivalents to Imbruvica Tablets).

ANDA may be eligible for 180 days of marketing exclusivity at the time of potential launch of the product under certain circumstances.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.

Natco Pharma Share Price

933.60 -15.25 (-1.61%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×